Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;26(4):512-535.
doi: 10.1111/hiv.13756. Epub 2025 Jan 2.

Transitions in treatment: A systematic review and meta-aggregation of preferences and barriers in switching from oral to long-acting injectable antiretroviral therapy among people living with HIV and stakeholders

Tiantian Hu  1 , Shuqi Yang  1 , Junwen Yu  1 , Zhongfang Yang  1 , Yilin Jin  1 , Zheng Zhu  1   2
Affiliations

Transitions in treatment: A systematic review and meta-aggregation of preferences and barriers in switching from oral to long-acting injectable antiretroviral therapy among people living with HIV and stakeholders

Tiantian Hu et al. HIV Med. 2025 Apr.

Abstract

Introduction: Antiretroviral treatment (ART) has significantly enhanced health outcomes for people living with HIV (PLWH). With the evolution of treatment options, there is an increasing interest in the development of long-acting injectable formulations of antiretroviral drugs. These formulations present a promising alternative to oral ART.

Methods: The methodology and reporting of this systematic review followed the guidance of the Joanna Briggs Institute Reviewer's Manual and Enhancing Transparency in Reporting the Synthesis of Qualitative Research (ENTREQ). The comprehensive searches involved multiple databases, including PubMed, MEDLINE (Ovid), Embase (Ovid), CINHAL (EBSCO), ProQuest Dissertations and Theses, Web of Science, Wanfang (Chinese), CNKI (Chinese), Google Scholar and Baidu Scholar (Chinese).

Results: In all, 142 studies were identified and 20 eligible studies were included in the meta-aggregation. A total of 141 findings, 20 categories and nine synthesized findings were extracted from 20 studies. The nine synthesized findings identified from the 20 studies focused on the following topics: benefits, flexibility and practicality of long-acting injectable (LAI) treatment; scepticism about the use of LAI treatment; management challenges; logistical challenges; potential for protecting marginalized populations; concerns about side effects; financial issue; suggestions for improvement. PLWH's geographical distribution, backgrounds, demographics and clinical characteristics were limited.

Conclusion: We recommend considering the needs and experiences of PLWH in the transition from oral ART to LAI treatment. For marginalized populations, it is crucial to maintain regular communication with healthcare providers and institutions. Additionally, at the community level, engaging diverse stakeholders with valuable insights is vital, as is enhancing health education programmes and intensifying efforts to combat discrimination. These measures will play a key role in addressing the needs of PLWH, enhancing public awareness and promoting better understanding of LAI treatment.

Keywords: HIV; antiretroviral treatment (ART); long‐acting injectable (LAI) treatment; meta‐aggregation; people living with HIV (PLWH); systematic review.

PubMed Disclaimer

References

REFERENCES

    1. Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451‐452.
    1. Saag MS, Benson CA, Gandhi RT, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international Antiviral society–USA panel. JAMA. 2018;320(4):379‐396.
    1. Kanters S, Vitoria M, Doherty M, et al. Comparative efficacy and safety of first‐line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta‐analysis. Lancet HIV. 2016;3(11):e510‐e520.
    1. Nachega JB, Scarsi KK, Gandhi M, et al. Long‐acting antiretrovirals and HIV treatment adherence. Lancet HIV. 2023;10:e332‐e342.
    1. Schatz E, Knight L, Mukumbang FC, Teti M, Myroniuk TW. ‘You have to withstand that because you have come for what you have come for’: barriers and facilitators to antiretroviral treatment access among older south Africans living with HIV. Sociol Health Illn. 2021;43(3):624‐641.

Publication types

MeSH terms

LinkOut - more resources